Medicare Quality Cancer Care Demonstration Act

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

The United States Medicare Quality Cancer Care Demonstration Act of 2009 (H.R. 2872) is a landmark, national initiative intended to enhance the quality of cancer care, focused on seniors covered by Medicare (approximately 45% of cancer patients are Medicare beneficiaries), while also controlling costs. House bill H.R. 2872 was introduced by Congressman Artur Davis (D-AL) and cosponsored by Representatives Steve Israel (D-NY) and Mary Jo Kilroy (D-OH).

The Quality Cancer Care Demonstration (QCCD) project was developed by community oncologists, with input from policy experts, to be a national Medicare demonstration project focused on two key aspects of cancer care: treatment planning and end-of-life care. Treatment planning involves all of the essential components of establishing the cancer care plan and monitoring its effectiveness. End-of-life care involves all of the essential components of patient-centric cancer care relating to individuals facing end-of-life planning and decisions.

H.R. 2872 calls for national reporting, via the Medicare payment system, of key metrics of evidence based care, refinement of those metrics, and development of a new Medicare performance-based reimbursement system that is patient-centric and quality driven, while aligning better with parameters of cost control.

The bill includes the following elements:[1]

  • Establish a national Medicare demonstration project implemented by the Centers for Medicare & Medicaid Services (CMS) and open to all oncology practices.
  • Address current shortcomings in treatment planning and end-of-life care by improving metrics and aligning incentives relating to that care.
  • Having oncologists to report (through the Medicare reimbursement system) quality measures concerning their treatment plans and end-of-life care. It would include refinement and improvement of those plans.
  • Allocate $300 million per year in Medicare funding to revise the Medicare payment system. Those payments would be based on quality and cost-efficiency.
  • Incorporate the key elements under discussion in the healthcare reform debate — quality care delivery, evidence-based medicine, care coordination, patient-centric, cost control, health information technology, and pay-for-performance — in producing an evolved payment system.
  • Evaluation of QCCD to determine participation of oncologists and cost effectiveness of the plan.
  • Conducting of the demonstration project over a period of not less than two years to allow for improvement of reporting, metrics, and analysis.
  • A substantive project that can be implemented within 6 months by CMS and be available to all oncologists nationwide.
  • Could serve as a model for other areas of specific care relating to terminal illness for Medicare beneficiaries.

See also[edit]


  1. ^ "Medicare Quality Cancer Care Demonstration Act of 2009 -". Retrieved 2016-08-09.